Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020.
Appears in 21 contracts
Sources: Securities Purchase Agreement (Inmune Bio, Inc.), Securities Purchase Agreement (Lixte Biotechnology Holdings, Inc.), Underwriting Agreement (Enservco Corp)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 1020-K F for the fiscal year ended December 31, 20202019.
Appears in 13 contracts
Sources: Placement Agency Agreement (Nano Dimension Ltd.), Placement Agency Agreement (Nano Dimension Ltd.), Placement Agency Agreement (Nano Dimension Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202023.
Appears in 12 contracts
Sources: Securities Purchase Agreement (Theriva Biologics, Inc.), Securities Purchase Agreement (Theriva Biologics, Inc.), Securities Purchase Agreement (Theriva Biologics, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202022.
Appears in 10 contracts
Sources: Securities Purchase Agreement (Cosmos Health Inc.), Securities Purchase Agreement (Quoin Pharmaceuticals, Ltd.), Securities Purchase Agreement (Quoin Pharmaceuticals, Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December October 31, 20202018.
Appears in 10 contracts
Sources: Underwriting Agreement (ShiftPixy, Inc.), Underwriting Agreement (ShiftPixy, Inc.), Underwriting Agreement (ShiftPixy, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Pricing Prospectus and the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202025.
Appears in 10 contracts
Sources: Securities Purchase Agreement (Pasithea Therapeutics Corp.), Securities Purchase Agreement (Pasithea Therapeutics Corp.), Securities Purchase Agreement (Bionano Genomics, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202022.
Appears in 9 contracts
Sources: Securities Purchase Agreement (Greenlane Holdings, Inc.), Securities Purchase Agreement (Greenlane Holdings, Inc.), Securities Purchase Agreement (Enservco Corp)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202019.
Appears in 9 contracts
Sources: Securities Purchase Agreement (Genprex, Inc.), Underwriting Agreement (BioCardia, Inc.), Underwriting Agreement (BioCardia, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusSEC Reports. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202024.
Appears in 9 contracts
Sources: Securities Purchase Agreement (Maris Tech Ltd.), Securities Purchase Agreement (Wearable Devices Ltd.), Securities Purchase Agreement (Wearable Devices Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Preliminary Prospectus and Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202024.
Appears in 9 contracts
Sources: Securities Purchase Agreement (Aptera Motors Corp), Securities Purchase Agreement (Aptera Motors Corp), Securities Purchase Agreement (Aptera Motors Corp)
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusSEC Reports. To the knowledge and belief of the Company’s knowledge, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express has expressed its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202021.
Appears in 8 contracts
Sources: Securities Purchase Agreement (Allarity Therapeutics, Inc.), Securities Purchase Agreement (Guardion Health Sciences, Inc.), Securities Purchase Agreement (Tonix Pharmaceuticals Holding Corp.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusSEC Reports. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202025.
Appears in 8 contracts
Sources: Securities Purchase Agreement (Tempest Therapeutics, Inc.), Securities Purchase Agreement (Aptorum Group LTD), Securities Purchase Agreement (Aclarion, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202023.
Appears in 7 contracts
Sources: Securities Purchase Agreement (Inhibikase Therapeutics, Inc.), Securities Purchase Agreement (Inhibikase Therapeutics, Inc.), Securities Purchase Agreement (Inhibikase Therapeutics, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusProspectus Supplement. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202024.
Appears in 7 contracts
Sources: Securities Purchase Agreement (WORK Medical Technology Group LTD), Securities Purchase Agreement (Ostin Technology Group Co., Ltd.), Securities Purchase Agreement (Lichen China LTD)
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusProspectus Supplement. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202022.
Appears in 7 contracts
Sources: Securities Purchase Agreement (Tonix Pharmaceuticals Holding Corp.), Securities Purchase Agreement (Tonix Pharmaceuticals Holding Corp.), Securities Purchase Agreement (Tonix Pharmaceuticals Holding Corp.)
Accountants. The Company’s independent registered public accounting firm is firms are as set forth in the ProspectusProspectus for the Company and its predecessor. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202022.
Appears in 6 contracts
Sources: Securities Purchase Agreement (ZyVersa Therapeutics, Inc.), Securities Purchase Agreement (ZyVersa Therapeutics, Inc.), Securities Purchase Agreement (ZyVersa Therapeutics, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusSEC Reports. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202024.
Appears in 6 contracts
Sources: Securities Purchase Agreement (SRM Entertainment, Inc.), Securities Purchase Agreement (Pasithea Therapeutics Corp.), Securities Purchase Agreement (XWELL, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth named in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31ending June 30, 2020.
Appears in 6 contracts
Sources: Securities Purchase Agreement (Genetic Technologies LTD), Securities Purchase Agreement (Genetic Technologies LTD), Securities Purchase Agreement (Genetic Technologies LTD)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202018.
Appears in 6 contracts
Sources: Securities Purchase Agreement (Therapix Biosciences Ltd.), Securities Purchase Agreement (Therapix Biosciences Ltd.), Securities Purchase Agreement (Therapix Biosciences Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Preliminary Prospectus and Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202023.
Appears in 6 contracts
Sources: Securities Purchase Agreement (Soligenix, Inc.), Securities Purchase Agreement (Soligenix, Inc.), Securities Purchase Agreement (Zivo Bioscience, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202019.
Appears in 6 contracts
Sources: Securities Purchase Agreement (Therapix Biosciences Ltd.), Securities Purchase Agreement (Safe-T Group Ltd.), Securities Purchase Agreement (Kitov Pharma Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Preliminary Prospectus and the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202024.
Appears in 6 contracts
Sources: Placement Agency Agreement (Chanson International Holding), Placement Agency Agreement (Chanson International Holding), Securities Purchase Agreement (Petros Pharmaceuticals, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December ending July 31, 20202023.
Appears in 5 contracts
Sources: Securities Purchase Agreement (ONCOSEC MEDICAL Inc), Securities Purchase Agreement (ONCOSEC MEDICAL Inc), Securities Purchase Agreement (ONCOSEC MEDICAL Inc)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31June 30, 20202019.
Appears in 4 contracts
Sources: Underwriting Agreement (iBio, Inc.), Underwriting Agreement (iBio, Inc.), Underwriting Agreement (iBio, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Preliminary Prospectus and Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December August 31, 20202023.
Appears in 4 contracts
Sources: Securities Purchase Agreement (ShiftPixy, Inc.), Securities Purchase Agreement (Alpine 4 Holdings, Inc.), Securities Purchase Agreement (ShiftPixy, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Preliminary Prospectus and the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31ending June 30, 20202026.
Appears in 4 contracts
Sources: Securities Purchase Agreement (Linkers Industries LTD), Securities Purchase Agreement (Linkers Industries LTD), Placement Agency Agreement (Linkers Industries LTD)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202023.
Appears in 4 contracts
Sources: Warrants Purchase Agreement (Xylo Technologies LTD), Securities Purchase Agreement (Chemomab Therapeutics Ltd.), Securities Purchase Agreement (T2 Biosystems, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Preliminary Prospectus and the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31ending September 30, 20202025.
Appears in 4 contracts
Sources: Securities Purchase Agreement (Globavend Holdings LTD), Securities Purchase Agreement (Globavend Holdings LTD), Placement Agency Agreement (Globavend Holdings LTD)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express has expressed its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202022.
Appears in 4 contracts
Sources: Securities Purchase Agreement (Allarity Therapeutics, Inc.), Securities Purchase Agreement (Allarity Therapeutics, Inc.), Securities Purchase Agreement (Allarity Therapeutics, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusRegistration Statement. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202023.
Appears in 4 contracts
Sources: Securities Purchase Agreement (Akanda Corp.), Securities Purchase Agreement (Akanda Corp.), Securities Purchase Agreement (Akanda Corp.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202024.
Appears in 4 contracts
Sources: Securities Purchase Agreement (Wearable Devices Ltd.), Securities Purchase Agreement (Wearable Devices Ltd.), Securities Purchase Agreement (Volato Group, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202022.
Appears in 3 contracts
Sources: Securities Purchase Agreement (Inuvo, Inc.), Securities Purchase Agreement (Acurx Pharmaceuticals, Inc.), Securities Purchase Agreement (Alpine 4 Holdings, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Preliminary Prospectus and Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202025.
Appears in 3 contracts
Sources: Securities Purchase Agreement (BioCardia, Inc.), Securities Purchase Agreement (Mercurity Fintech Holding Inc.), Securities Purchase Agreement (BioCardia, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusProspectus Supplement. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 2020.
Appears in 3 contracts
Sources: Securities Purchase Agreement (Kitov Pharma Ltd.), Securities Purchase Agreement (BioLineRx Ltd.), Securities Purchase Agreement (BioLineRx Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202023.
Appears in 3 contracts
Sources: Securities Purchase Agreement (Galmed Pharmaceuticals Ltd.), Securities Purchase Agreement (Galmed Pharmaceuticals Ltd.), Securities Purchase Agreement (Galmed Pharmaceuticals Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Preliminary Prospectus and Prospectus. To the knowledge and belief of the Company’s knowledge, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202025.
Appears in 3 contracts
Sources: Securities Purchase Agreement (Veea Inc.), Securities Purchase Agreement (Veea Inc.), Securities Purchase Agreement (Veea Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Preliminary Prospectus and the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended on December 31, 20202024.
Appears in 3 contracts
Sources: Securities Purchase Agreement (Lobo Technologies Ltd.), Securities Purchase Agreement (Chanson International Holding), Securities Purchase Agreement (Chanson International Holding)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 1020-K F for the fiscal year ended December 31, 2020.
Appears in 3 contracts
Sources: Securities Purchase Agreement (MMTec, Inc.), Securities Purchase Agreement (Foresight Autonomous Holdings Ltd.), Securities Purchase Agreement (Tiziana Life Sciences PLC)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Pricing Prospectus and the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202025.
Appears in 3 contracts
Sources: Securities Purchase Agreement (Can-Fite BioPharma Ltd.), Securities Purchase Agreement (Can-Fite BioPharma Ltd.), Securities Purchase Agreement (Can-Fite BioPharma Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202025.
Appears in 3 contracts
Sources: Securities Purchase Agreement (FBS Global LTD), Securities Purchase Agreement (Brenmiller Energy Ltd.), Securities Purchase Agreement (Brenmiller Energy Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202024.
Appears in 3 contracts
Sources: Securities Purchase Agreement (Quoin Pharmaceuticals, Ltd.), Securities Purchase Agreement (Quoin Pharmaceuticals, Ltd.), Securities Purchase Agreement (Aptose Biosciences Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202024. The Company changed its independent registered public accounting firm on July 11, 2024. The newly engaged independent registered public accounting firm qualifies as a registered public accounting firm as required by the Exchange Act.
Appears in 3 contracts
Sources: Securities Purchase Agreement (Qualigen Therapeutics, Inc.), Securities Purchase Agreement (Qualigen Therapeutics, Inc.), Securities Purchase Agreement (Qualigen Therapeutics, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Pricing Prospectus and the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and Act, (ii) shall express has expressed its opinion with respect to the financial statements to be included in the Registration Statement, and (iii) has reviewed the interim financial statements relating to the Company’s Annual Report on Form 10-K for financial results after the fiscal last year ended December 31, 2020end audit.
Appears in 2 contracts
Sources: Securities Purchase Agreement (CCSC Technology International Holdings LTD), Securities Purchase Agreement (CCSC Technology International Holdings LTD)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Pricing Prospectus and the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202024.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Silexion Therapeutics Corp), Securities Purchase Agreement (Silexion Therapeutics Corp)
Accountants. The Company’s independent registered public accounting firm is as firms are set forth in the Prospectus. To the knowledge and belief of the Company, each such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) Audit Alliance LLP shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31on October 30, 20202025.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Jiuzi Holdings, Inc.), Placement Agency Agreement (Jiuzi Holdings, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Preliminary Prospectus and Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202025.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Soligenix, Inc.), Securities Purchase Agreement (Soligenix, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Preliminary Prospectus and the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31on June 30, 20202024.
Appears in 2 contracts
Sources: Securities Purchase Agreement (EPWK Holdings Ltd.), Securities Purchase Agreement (EPWK Holdings Ltd.)
Accountants. The Company’s current independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 1020-K F for the fiscal year ended December 31, 20202024.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Belite Bio, Inc), Securities Purchase Agreement (Tiziana Life Sciences LTD)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Pricing Prospectus and the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act Act, and (ii) shall express has expressed its opinion with respect to the financial statements to be included in the Registration Statement, and (iii) has reviewed the interim financial statements relating to the Company’s Annual Report on Form 10-K for financial results aafter the fiscal last year ended December 31, 2020end audit.
Appears in 2 contracts
Sources: Placement Agency Agreement (CCSC Technology International Holdings LTD), Placement Agency Agreement (CCSC Technology International Holdings LTD)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202017.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Can-Fite BioPharma Ltd.), Securities Purchase Agreement (Can-Fite BioPharma Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusProspectus Supplement. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202023.
Appears in 2 contracts
Sources: Securities Purchase Agreement (NeuroSense Therapeutics Ltd.), Securities Purchase Agreement (Precipio, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202025.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Jeffs' Brands LTD), Securities Purchase Agreement (Jeffs' Brands LTD)
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusSEC Reports. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 2020.
Appears in 2 contracts
Sources: At the Market Offering Agreement (Enlivex Therapeutics Ltd.), At the Market Offering Agreement (BioLineRx Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusProspectus Supplement. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202025.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Inspira Technologies OXY B.H.N. LTD), Securities Purchase Agreement (Tonix Pharmaceuticals Holding Corp.)
Accountants. The Company’s independent registered public accounting firm is as set forth identified in the Prospectus. To the knowledge and belief of the Company, such accounting firm firm: (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall is expected to express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202016.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Bellerophon Therapeutics, Inc.), Securities Purchase Agreement (Bellerophon Therapeutics, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202021.
Appears in 2 contracts
Sources: Securities Purchase Agreement (INVO Bioscience, Inc.), Securities Purchase Agreement (Orbital Energy Group, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Safe-T Group Ltd.), Securities Purchase Agreement (Safe-T Group Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth identified in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202012.
Appears in 2 contracts
Sources: Subscription Agreement (ARCA Biopharma, Inc.), Subscription Agreement (ARCA Biopharma, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Pricing Prospectus and the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202025.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Purple Biotech Ltd.), Securities Purchase Agreement (Purple Biotech Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202025.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Lottery.com Inc.), Placement Agency Agreement (Aquabounty Technologies Inc)
Accountants. The Company’s independent registered public accounting firm is as firms are set forth in the Prospectus. To the knowledge and belief of the Company, each such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) Assentsure PAC shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December on March 31, 20202026.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Meiwu Technology Co LTD), Securities Purchase Agreement (UTime LTD)
Accountants. The Company’s current independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202024.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Quantum Computing Inc.), Securities Purchase Agreement (Quantum Computing Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act Act, and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K annual report for the fiscal year ended December 31, 20202023.
Appears in 2 contracts
Sources: Securities Purchase Agreement (NaaS Technology Inc.), Securities Purchase Agreement (NaaS Technology Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusSEC Reports. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 2020.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Hancock Jaffe Laboratories, Inc.), Securities Purchase Agreement (Hancock Jaffe Laboratories, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 2020.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Can-Fite BioPharma Ltd.), Securities Purchase Agreement (Can-Fite BioPharma Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall expressed its opinion with respect to the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and will express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202022.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Oncocyte Corp), Securities Purchase Agreement (Verb Technology Company, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020.2022.
Appears in 1 contract
Sources: Securities Purchase Agreement (Quoin Pharmaceuticals, Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202021.
Appears in 1 contract
Sources: Securities Purchase Agreement (Can-Fite BioPharma Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth identified in the Prospectus. To the knowledge and belief of the Company, such accounting firm firm: (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202013.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall is expected to express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31ending June 30, 20202023.
Appears in 1 contract
Sources: Securities Purchase Agreement (Glimpse Group, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202023.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusSEC Reports. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202025.
Appears in 1 contract
Sources: Securities Purchase Agreement (Quoin Pharmaceuticals, Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December July 31, 20202019.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202023.
Appears in 1 contract
Sources: Securities Purchase Agreement (Ekso Bionics Holdings, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall will express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202021.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusProspectus Supplement. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31ending June 30, 20202025.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusProspectus Supplement. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202019.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall will express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31April 30, 20202022.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth named in the ProspectusProspectus under the heading “Experts.”. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202018.
Appears in 1 contract
Sources: Securities Purchase Agreement (Odyssey Marine Exploration Inc)
Accountants. The Company’s independent registered public accounting firm is as set forth named in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31ending June 30, 20202019.
Appears in 1 contract
Sources: Securities Purchase Agreement (Genetic Technologies LTD)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall expressed its opinion with respect to the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and will express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202022.
Appears in 1 contract
Sources: Securities Purchase Agreement (Verb Technology Company, Inc.)
Accountants. The Company’s independent registered public accounting firm is as firms are set forth in the Prospectus. To the knowledge and belief of the Company, each such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) Li CPA LLC shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending on December 31, 20202025.
Appears in 1 contract
Sources: Securities Purchase Agreement (MingZhu Logistics Holdings LTD)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall will express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31April 30, 20202023.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth identified in the Prospectus. To the knowledge and belief of the Company, such accounting firm firm: (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202014.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the Pricing Prospectus and the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202023.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express has expressed its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December July 31, 20202023.
Appears in 1 contract
Sources: Securities Purchase Agreement (BriaCell Therapeutics Corp.)
Accountants. The Company’s independent registered public accounting firm is as set forth named in the ProspectusProspectus Supplement. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31ending June 30, 2020.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the Preliminary Prospectus and Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31ending June 30, 20202024.
Appears in 1 contract
Sources: Securities Purchase Agreement (Kintara Therapeutics, Inc.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31September 30, 20202023.
Appears in 1 contract
Sources: Securities Purchase Agreement (Starbox Group Holdings Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020.
Appears in 1 contract
Sources: Securities Purchase Agreement (Verb Technology Company, Inc.)
Accountants. The Company’s independent registered public accounting firm is as firms are set forth in the Prospectus. To the knowledge and belief of the Company, each such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) [___] shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended on December 31, 20202025.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusProspectus Supplement. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202024.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusProspectus Supplement. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31ending June 30, 20202023.
Appears in 1 contract
Sources: Securities Purchase Agreement (Genetic Technologies LTD)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the 2021 fiscal year ended December 31, 2020year.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the Pricing Prospectus and the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express has expressed its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202024.
Appears in 1 contract
Sources: Securities Purchase Agreement (Soluna Holdings, Inc)
Accountants. The Company’s independent registered public accounting firm is as set forth in the ProspectusProspectus Supplement. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended ending December 31, 20202021.
Appears in 1 contract
Sources: Securities Purchase Agreement (CollPlant Biotechnologies LTD)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall is expected to express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31ending September 30, 20202023.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 1020-K F for the fiscal year ended December 31, 20202018.
Appears in 1 contract
Sources: Underwriting Agreement (Foresight Autonomous Holdings Ltd.)
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December October 31, 20202019.
Appears in 1 contract
Accountants. The Company’s independent registered public accounting firm is as set forth in the Prospectus. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall will express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 1020-K F for the fiscal year ended December August 31, 20202022.
Appears in 1 contract
Sources: Securities Purchase Agreement (Tanzanian Gold Corp)